Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL4411335

CCN1c2ccccc2SC1S(=O)(=O)O.N.N

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 2/20 0.38
▸ BCHE P06276 6/20 0.36
▸ PPARG P37231 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ MAPT P10636 3/20 0.34
▸ POLB P06746 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ ACHE P22303 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ MMP13 P45452 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL3860163 1.00 GSK3B (0.38) GSK3BBCHEPPARGALDH1A1SMN1; SMN2
Ammonia Solution, Strong SCHEMBL30286004 1.00 GSK3B (0.38) GSK3BBCHEPPARGALDH1A1SMN1; SMN2
Ammonia Solution, Strong SCHEMBL28099769 1.00 GSK3B (0.38) GSK3BBCHEPPARGALDH1A1SMN1; SMN2
SCHEMBL29366806 0.98 GSK3B (0.38) GSK3BBCHEPPARGALDH1A1SMN1; SMN2
SCHEMBL378842 0.98 GSK3B (0.38) GSK3BBCHEPPARGALDH1A1SMN1; SMN2
SCHEMBL15876008 0.78 AVPR2 (0.31) GSK3BBCHEKMT2A
SCHEMBL21647910 0.77 BCHE (0.37) GSK3BBCHEPPARGALDH1A1SMN1; SMN2
SCHEMBL3952904 0.77 CRHBP (0.35) —
SCHEMBL10481670 0.75 — —
SCHEMBL8342783 0.73 ALDH1A1 (0.35) GSK3BBCHEPPARGALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2585110-A1 ANTIBODIES TO THE C3D FRAGMENT OF COMPLEMENT COMPONENT 3 The Regents of the University of Colorado, A Body Corporate (US) 2013-05-01 — — EP disclosed
US-7863007-B2 Marker for prolonged rupture of membranes SWISS ASIAN PROPERTY LIMITED (HK) 2011-01-04 — — US disclosed
US-20090068692-A1 MARKER FOR PROLONGED RUPTURE OF MEMBRANES SWISS ASIAN PROPERTY LIMITED (HK) 2009-03-12 — — US disclosed
EP-1937709-A1 A MARKER FOR PROLONGED RUPTURE OF MEMBRANES Bio Source (Wuhan) Technology Ltd. (CN) 2008-07-02 — — EP disclosed
WO-2007030890-A1 A MARKER FOR PROLONGED RUPTURE OF MEMBRANES BIO SOURCE (WUHAN) TECHNOLOGY LTD (CN) 2007-03-22 — — WO disclosed
WO-2003018634-A1 MONOCLONAL ANTIBODY CB874 DIRECTED TO AN UNKNOWN ANTIGEN FROM UMBILICAL CORD BLOOD VOROTELIAK VICTOR (AU) 2003-03-06 — — WO disclosed
EP-0689552-B1 A METHOD OF DETECTING RUPTURE OF THE AMNIOTIC MEMBRANES IN PREGANT MAMMALS VOROTELIAK VICTOR (AU) 2002-10-30 — — EP disclosed
WO-2002064633-A1 MONOCLONAL ANTIBODY AGAINST AN UNKNOWN ANTIGEN FROM AMNIOTIC FLU ID AND ITS METHOD OF PREPARATION VOROTELIAK VICTOR (AU) 2002-08-22 — — WO disclosed
US-5783396-A ANTIGEN LOCATED IN AMNIOTIC FLUID HAVING SPECIFIED PHYSICAL PROPERTIES; USED TO PRODUCE ANTIBODY AGAINST AMNIOTIC FLUID FOR IMMUNOASSAY VOROTELIAK VICTOR (AU) 1998-07-21 — — US disclosed
EP-0689552-A4 A METHOD OF DETECTING RUPTURE OF THE AMNIOTIC MEMBRANES IN PREGANT MAMMALS VOROTELIAK VICTOR (AU) 1997-07-02 — — EP disclosed
EP-0689552-A1 A METHOD OF DETECTING RUPTURE OF THE AMNIOTIC MEMBRANES IN PREGANT MAMMALS VOROTELIAK, Victor (AU) 1996-01-03 — — EP disclosed
WO-1994021687-A1 A METHOD OF DETECTING RUPTURE OF THE AMNIOTIC MEMBRANES IN PREGANT MAMMALS VOROTELIAK VICTOR (AU) 1994-09-29 — — WO disclosed
Send feedback